Pyxis Oncology Inc (PYXS) Stock Price

3.27 ▼ -0.11 (-3.25%)
Open: 3.42 Vol: 738.34K Day's range: 3.18 - 3.4367 Sep 10, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PYXS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 3.24▲ 3.26▲ 3.27▼ 3.60▼ 3.30▼
MA10 3.24▲ 3.26▲ 3.34▼ 3.50▼ 3.05▲
MA20 3.24▲ 3.36▼ 3.60▼ 3.30▼ 2.60▲
MA50 3.26▲ 3.70▼ 3.62▼ 3.00▲ 2.47▲
MA100 3.35▼ 3.59▼ 3.38▼ 2.49▲ 2.05▲
MA200 3.59▼ 3.37▼ 3.30▼ 2.26▲ 2.47▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.004▲ 0.005▲ -0.049▼ -0.007▼ 0.112▲
RSI 54.948▲ 33.551▼ 32.932▼ 49.996▼ 57.272▲
STOCH 89.048▲ 30.063     11.440▼ 64.859     70.577    
WILL %R 0.000▲ -77.273▼ -91.848▼ -66.415     -33.716    
CCI 191.011▲ -63.765     -77.300     -23.435     109.276▲
Latest Filters Detected On PYXS
RSI $PYXS RSI(14) Crossed Below 50 Set Alert
▼ MACD $PYXS MACD(12,26,9) Crossed Below Signal Line Set Alert
MA $PYXS Price Crossed Below MA(26) Set Alert
Pyxis Oncology Inc News
Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck ...
Wednesday, September 09, 2026 04:00 AM
MICVO demonstrated rapid and deep responses, with a 36% confirmed objective response rate (cORR) and 94% disease control rate (DCR), with clinical activity observed across HPV status and ...
Pyxis Oncology shares fall 7% despite updated MICVO trial results
Wednesday, September 09, 2026 04:00 AM
Pyxis Oncology (NASDAQ:PYXS) shares fell 7% on Tuesday after the biotechnology company released updated Phase 1 data for Micvotabart Pelidotin, or MICVO, in patients with previously treated recurrent ...
Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and ...
Tuesday, September 08, 2026 01:01 PM
Event to be webcast live on September 9, 2026 at 7:30 a.m. ETBOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for ...
PYXS historical stock data
date open high low close volume
10/09/26 3.42 3.4367 3.18 3.27 738,335
09/09/26 3.48 4.12 3.132 3.38 4,340,627
08/09/26 4.00 4.15 3.845 3.89 1,268,686
04/09/26 3.53 4.05 3.515 3.89 2,230,329
03/09/26 3.71 3.74 3.45 3.565 811,837
02/09/26 3.45 3.77 3.435 3.75 722,369
01/09/26 3.24 3.57 3.18 3.44 589,133
31/08/26 3.20 3.28 3.0501 3.24 465,867
28/08/26 3.32 3.3796 3.2001 3.23 211,989
27/08/26 3.31 3.37 3.23 3.32 396,722
Quote Details
52wk Low:1.03
52wk High:5.55
Vol:738.34K
Avg Vol(3m):20.6M
1Y Chng:+52.80%
1M Chng:+13.94%
Add to Watch List
More Information
Index US Composite
Market Cap. 281.92M